Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 1
2007 1
2008 2
2009 2
2010 7
2011 10
2012 8
2013 5
2014 11
2015 11
2016 10
2017 7
2018 11
2019 4
2020 15
2021 13
2022 15
2023 18
2024 12
2025 26

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution.
Pedersen L, Idorn M, Olofsson GH, Lauenborg B, Nookaew I, Hansen RH, Johannesen HH, Becker JC, Pedersen KS, Dethlefsen C, Nielsen J, Gehl J, Pedersen BK, Thor Straten P, Hojman P. Pedersen L, et al. Among authors: pedersen ks. Cell Metab. 2016 Mar 8;23(3):554-62. doi: 10.1016/j.cmet.2016.01.011. Epub 2016 Feb 16. Cell Metab. 2016. PMID: 26895752 Free article.
Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology.
Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, Cohen SA, Cooper HS, Deming DA, Garrido-Laguna I, Grem JL, Hoffe SE, Hubbard J, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen KS, Saltz LB, Schneider C, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Johnson-Chilla A, Gregory KM, Gurski LA. Benson AB, et al. Among authors: pedersen ks. J Natl Compr Canc Netw. 2019 Sep 1;17(9):1109-1133. doi: 10.6004/jnccn.2019.0043. J Natl Compr Canc Netw. 2019. PMID: 31487687 Free PMC article.
Trichophyton verrucosum.
Svendsen SV, Astvad KMT, Lützen L, Pedersen KS, Svendsen MT. Svendsen SV, et al. Among authors: pedersen ks. Ugeskr Laeger. 2024 Jul 1;186(27):V72018. doi: 10.61409/V72018. Ugeskr Laeger. 2024. PMID: 38953678 Free article. Danish. No abstract available.
Unleashing phosphorus mononitride.
Edin S, Sandoval-Pauker C, Yutronkie NJ, Takacs Z, Wilhelm F, Rogalev A, Pinter B, Pedersen KS, Reinholdt A. Edin S, et al. Among authors: pedersen ks. Nat Commun. 2025 Jul 1;16(1):5596. doi: 10.1038/s41467-025-60669-6. Nat Commun. 2025. PMID: 40595554 Free PMC article.
Immunotherapy for Colorectal Cancer.
Mukherji R, Weinberg BA, Pedersen KS. Mukherji R, et al. Among authors: pedersen ks. Hematol Oncol Clin North Am. 2022 Jun;36(3):603-626. doi: 10.1016/j.hoc.2022.02.010. Epub 2022 May 13. Hematol Oncol Clin North Am. 2022. PMID: 35577706 Review.
Neoadjuvant BMS-813160, Nivolumab, Gemcitabine, and Nab-Paclitaxel for Patients with Pancreatic Cancer.
Grierson PM, Wolf C, Suresh R, Wang-Gillam A, Tan BR, Ratner L, Oppelt P, Aranha O, Frith A, Pedersen KS, Spann J, Boice N, Brown A, Baer JM, Butka EG, Ahmad F, Xu Y, Liu J, DeNardo DG, Lim KH. Grierson PM, et al. Among authors: pedersen ks. Clin Cancer Res. 2025 Sep 2;31(17):3644-3651. doi: 10.1158/1078-0432.CCR-24-1821. Clin Cancer Res. 2025. PMID: 40125795 Free PMC article. Clinical Trial.
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial.
Bockorny B, Semenisty V, Macarulla T, Borazanci E, Wolpin BM, Stemmer SM, Golan T, Geva R, Borad MJ, Pedersen KS, Park JO, Ramirez RA, Abad DG, Feliu J, Muñoz A, Ponz-Sarvise M, Peled A, Lustig TM, Bohana-Kashtan O, Shaw SM, Sorani E, Chaney M, Kadosh S, Vainstein Haras A, Von Hoff DD, Hidalgo M. Bockorny B, et al. Among authors: pedersen ks. Nat Med. 2020 Jun;26(6):878-885. doi: 10.1038/s41591-020-0880-x. Epub 2020 May 25. Nat Med. 2020. PMID: 32451495 Clinical Trial.
Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors with Peritoneal Involvement.
Godfrey EL, Mahoney F, Bansal VV, Su DG, Hanna DN, Lopez-Ramirez F, Baron E, Turaga KK, Benson AB 3rd, Setia N, Winer JH, Gunderson CG, Shah R, Magge DR, Solsky I, Eng C, Eng OS, Shergill A, Shen JP, Misdraji J, Foote MB, Luo W; Peritoneal Surface Malignancies (PSM) Consortium Group. Godfrey EL, et al. Ann Surg Oncol. 2025 Jun 25. doi: 10.1245/s10434-025-17364-z. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40560501
Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases.
Schultz KS, Bansal VV, Wach MM, Bhutiani N, Godley FA 4th, Wang JJ, Waheed MT, Buchheit JT, Papai E, Campbell S, Schleimer LE, Su DG, Turaga KK, Gunderson CG, White MG, Uppal A, Raghav KPS, Labow DM, Sarpel U, Shergill AP, Shen JP, Eng C, Foote MB, Baumgartner JM; Peritoneal Surface Malignancies (PSM) Consortium Group. Schultz KS, et al. Ann Surg Oncol. 2025 Jun 25. doi: 10.1245/s10434-025-17363-0. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40560497 Review.
177 results